Our results showed that in the liver of NDS-treated obese mice, angiotensinogen and AT1R mRNA were significantly decreased, as well as the circulating levels of ANG II, suggesting that the treatment with the natural supplement protects from NAFLD and atherogenesis by preventing RAS imbalance. This evidence concerns the gene AGT and metabolic dysfunction-associated steatotic liver disease.